Indefinite Delivery Contract HHSD200201562102I

The Department of Veterans Affairs (VA) has awarded a $5.4 billion Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) to Novartis Pharmaceuticals Corporation, a foreign-owned, for-profit manufacturer of pharmaceutical products. This IDV contract enables Novartis to provide a comprehensive range of pharmaceutical and drug products to support VA medical programs. Under this FSS contract, the VA has issued multiple delivery orders to Novartis for specialized cancer...

This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC as the prime contractor. The contract, valued at up to $1.25 billion, is part of the Vaccines for Children (VFC) 2015 program and provides for the delivery of various vaccines and pharmaceutical products to support federal immunization and disease prevention initiatives. Key products and services included under this multiple award IDV contract include seasonal influenza...

The Federal Supply Schedule (FSS) contract identified as 36F79720D0225 was awarded by the U.S. Department of Veterans Affairs (VA) to Novartis Gene Therapies Inc. on September 15, 2020. This multiple-award, indefinite delivery vehicle (IDV) contract is under the Pharmaceuticals and Drugs (FSS-61-IB) category, with a total ceiling value of $6,000,000,000 and a period of performance extending until September 14, 2026. The purpose of this contract is to provide the VA with a broad range of...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to Novartis Vaccines And Diagnostics, Inc., a foreign-owned for-profit organization. The $4,555,107.50 contract was a single award with a performance period ending on February 28, 2011. The IDC was awarded to provide TAS FLU 2010 VFA services, though the specific products and services to be delivered are not detailed in the...

This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...

This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $640,309,577 multiple-award contract, identified as VFA 2009, has an ultimate completion date of June 30, 2010. Under this IDC, Sanofi Pasteur Inc. is the prime contractor responsible for providing a range of vaccine products and services to support various federal...

This Indefinite Delivery Contract (IDC) was awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceuticals and medical goods. The IDC has a ceiling value of $645,550.20 and an ultimate completion date of November 13, 2024. Sanofi Pasteur Inc. has previously received awards from various federal agencies to supply vaccines and other medical countermeasures through IDVs and Federal Supply...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The $82,229,910.30 contract provides seasonal and pre-pandemic influenza vaccines, as well as other standard immunizations, to support disease prevention and public health preparedness for federal agencies. The IDC is a multiple award vehicle with a ceiling value of $82,229,910.30 and a period of...

This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer specializing in vaccines and medical supplies. The $15,226,000 multiple-award contract covers the procurement of adult COVID-19 vaccines for the period of June 1, 2025 through May 31, 2026. As a leading global vaccine provider, Sanofi Pasteur has secured numerous significant IDCs across various federal...

This federal contract IDV award from the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. is for the supply of 2025-2026 pediatric flu vaccines. The $70.18M multiple award contract has a period of performance through February 2026. As the prime contractor, Sanofi Pasteur will leverage its pharmaceutical manufacturing and distribution capabilities to fulfill task orders for pediatric influenza vaccines in support of the CDC's public health mission. The contract was...